Edwards Lifesciences (EW) PT Raised to $130 at Stifel; Reiterates Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Edwards Lifesciences (EW) PT Raised to $130 at Stifel; Reiterates Buy

Edwards Lifesciences Reports Second Quarter Results

July 26, 2017 4:15 PM EDT

IRVINE, Calif., July 26, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2017. 

Second Quarter and Recent Highlights:

Sales grew 11 percent to $842 million; underlying1 sales increased 15 percent to $864 million Global THVT sales grew 16 percent to $488 million; underlying sales increased 23 percent U.S. THVT sales grew 28 percent to $316 million EPS was $0.86, an increase of 48 percent; adjusted2... More